Transcriptomics

Dataset Information

0

Nilotinib (Tasigna) in the Treatment of Early Diffuse Systemic Sclerosis: An Open-Label, Pilot Clinical Trial


ABSTRACT: To assess the safety, efficacy, and molecular change associated with treatment of patients with early, diffuse cutaneous systemic sclerosis (dcSSc) with nilotinib (Tasigna™).

ORGANISM(S): Homo sapiens

PROVIDER: GSE65405 | GEO | 2015/08/27

SECONDARY ACCESSION(S): PRJNA273886

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2015-08-27 | E-GEOD-65405 | biostudies-arrayexpress
| S-EPMC4538758 | biostudies-literature
2018-03-01 | GSE97248 | GEO
2017-08-23 | GSE80342 | GEO
2016-02-01 | GSE66321 | GEO
| S-EPMC9197965 | biostudies-literature
| S-EPMC7978271 | biostudies-literature
2022-05-21 | GSE203443 | GEO
2022-05-21 | GSE203442 | GEO
2023-06-30 | GSE227347 | GEO